N. ELİYATKIN Et Al. , "The Role of p95HER2 in trastuzumab resistance in breast cancer," EACR Sponsored 3rd Anticancer Agent Development Congress , İzmir, Turkey, pp.56, 2015
ELİYATKIN, N. Et Al. 2015. The Role of p95HER2 in trastuzumab resistance in breast cancer. EACR Sponsored 3rd Anticancer Agent Development Congress , (İzmir, Turkey), 56.
ELİYATKIN, N., AKTAŞ, S., ÖZGÜR, H., ERÇETİN, A. P., & KÜPELİOĞLU, A., (2015). The Role of p95HER2 in trastuzumab resistance in breast cancer . EACR Sponsored 3rd Anticancer Agent Development Congress (pp.56). İzmir, Turkey
ELİYATKIN, NUKET Et Al. "The Role of p95HER2 in trastuzumab resistance in breast cancer," EACR Sponsored 3rd Anticancer Agent Development Congress, İzmir, Turkey, 2015
ELİYATKIN, NUKET Et Al. "The Role of p95HER2 in trastuzumab resistance in breast cancer." EACR Sponsored 3rd Anticancer Agent Development Congress , İzmir, Turkey, pp.56, 2015
ELİYATKIN, N. Et Al. (2015) . "The Role of p95HER2 in trastuzumab resistance in breast cancer." EACR Sponsored 3rd Anticancer Agent Development Congress , İzmir, Turkey, p.56.
@conferencepaper{conferencepaper, author={NUKET ELİYATKIN Et Al. }, title={The Role of p95HER2 in trastuzumab resistance in breast cancer}, congress name={EACR Sponsored 3rd Anticancer Agent Development Congress}, city={İzmir}, country={Turkey}, year={2015}, pages={56} }